JNJ
192.08
-0.38%↓
ABT
126.36
-1.14%↓
MDT
94.19
-1.71%↓
VEEV
291.41
+0.69%↑
A
147.65
+1.19%↑
JNJ
192.08
-0.38%↓
ABT
126.36
-1.14%↓
MDT
94.19
-1.71%↓
VEEV
291.41
+0.69%↑
A
147.65
+1.19%↑
JNJ
192.08
-0.38%↓
ABT
126.36
-1.14%↓
MDT
94.19
-1.71%↓
VEEV
291.41
+0.69%↑
A
147.65
+1.19%↑
JNJ
192.08
-0.38%↓
ABT
126.36
-1.14%↓
MDT
94.19
-1.71%↓
VEEV
291.41
+0.69%↑
A
147.65
+1.19%↑
JNJ
192.08
-0.38%↓
ABT
126.36
-1.14%↓
MDT
94.19
-1.71%↓
VEEV
291.41
+0.69%↑
A
147.65
+1.19%↑
24h
Current
Min
6.83
Max
7.19
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +205.32% upside |
Next Earnings | 10 lis 2025 |
|---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
27 lis 2024, 13:34 UTC
CervoMed Shares Rise 15% on FDA's Orphan Drug Designation for Neflamapimod
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 21.8 USD 205.32%
High 31 USD
Low 11 USD
Based on 5 Wall Street analysts offering 12 month price targets forCervoMed Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
5 ratings
4
Buy
1
Hold
0
Sell
Based on 5 analysts giving stock ratings to CervoMed Inc - Dist in the past 3 months.
$